chr11-57598271-A-C
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1PS1_ModeratePM2PP5_Moderate
The NM_000062.3(SERPING1):c.1A>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 31)
Consequence
SERPING1
NM_000062.3 start_lost
NM_000062.3 start_lost
Scores
6
4
6
Clinical Significance
Conservation
PhyloP100: 1.44
Genes affected
SERPING1 (HGNC:1228): (serpin family G member 1) This gene encodes a highly glycosylated plasma protein involved in the regulation of the complement cascade. Its encoded protein, C1 inhibitor, inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE). Alternative splicing results in multiple transcript variants encoding the same isoform. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_000062.3 (SERPING1) was described as [Pathogenic] in ClinVar as 626352
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-57598271-A-C is Pathogenic according to our data. Variant chr11-57598271-A-C is described in ClinVar as [Pathogenic]. Clinvar id is 626353.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-57598271-A-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SERPING1 | NM_000062.3 | c.1A>C | p.Met1? | start_lost | 2/8 | ENST00000278407.9 | |
SERPING1 | NM_001032295.2 | c.1A>C | p.Met1? | start_lost | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SERPING1 | ENST00000278407.9 | c.1A>C | p.Met1? | start_lost | 2/8 | 1 | NM_000062.3 | P2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary angioedema type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Department of Immunology and Histocompatibility, University of Thessaly | - | The c.1A>C (p.Met1Leu) variant has been previously reported in association with hereditary angioedema in the literature (Speletas et al., 2015; Loules et al., 2018). It is a regulatory mutation that alters the initiation codon of the transcript 001 of SERPING1 gene. It was detected by our laboratory in 1 male patient with C1-INH-HAE Type I and positive family history for the disease. It was not detected in a healthy family member that was also tested (patient's son). The variant has never been detected in approximately 120000 individuals of the Exome Aggregation Consortium (ExAC), indicating that it is not a common variant. There are three more mutations which change the initiation codon of the transcript and they have been previously reported in association with C1-INH HAE type I: c.1A>G (p.Met1Val), c.2T>G (p.Met1Arg) [Speletas et al. 2015] and c.2T>G (p.Met1Thr) [Bafunno V et al., 2014]. Taking all the above into account and according to ACMG Guidelines (Criteria: PVS1, PS1, PS4, PM2, PP1-S, PP4) the variant is considered pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;.;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;T;D;D;T;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D;D;N
PROVEAN
Benign
N;N;N;N;N;N;.
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D;D;T;.
Sift4G
Pathogenic
D;D;D;D;D;D;D
Polyphen
0.77, 0.87
.;P;.;.;.;P;.
Vest4
0.77, 0.81, 0.80, 0.44, 0.43
MutPred
0.38
.;.;Loss of catalytic residue at M35 (P = 0.0016);.;.;Loss of catalytic residue at M35 (P = 0.0016);.;
MVP
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at